bupivacaine HCl

bupivacaine HCl (local) (byōōpiv´əkān´),

n brand names: Marcaine, Senorcaine;
drug class: amide local anesthetic;
action: inhibits ion fluxes across membranes, particularly sodium transport across cell membranes; decreases rise of depolarization phase of action potential; blocks nerve action potential;
uses: local dental anesthesia, epidural anesthesia, peripheral nerve block, caudal anesthesia.
References in periodicals archive ?
Limited Tenders are invited for Supply of Inj Bupivacaine Hcl 0.
Durect reported that PERSIST, the Phase 3 clinical trial for POSIMIR, did not meet its primary efficacy endpoint of reduction in pain on movement over the first 48 hours after surgery as compared to standard bupivacaine HCl.
The comparison of clinical histopathological and hemodynamic effect of spinal anaesthesia applied in dogs through bupivacaine HCl and ropivacaine HCl in two different concentrations.
It is conducting PERSIST, a Phase 3 trial in patients undergoing laparoscopic cholecystectomy, comparing the effects of POSIMIR to bupivacaine HCl.
5 Bupivacaine HCl Deproco 2 Lidocaine HCl (Seotodom) 2 Lidocaine HCl 2 Mepivacaine HCl 3 Mepivacaine HCl 4 Articaine HCl 4 Articaine HCl Cook-Waite 2 Lidocaine HCl 2 Lidocaine HCl 3 Mepivacaine HCl 2 Mepivacaine HCl 4 Articaine HCl 4 Articaine HCl 0.
When retrospectively compared to a 2011 study of patients who received a TAP infiltration of bupivacaine HCl, patients administered EXPAREL in the same fashion had similar or better pain scores with a reduced requirement for opioids.
EXPAREL is a novel long-acting, sustained release formulation of bupivacaine HCl, a local anesthetic/analgesic widely used for treating post operative pain.
Bupivacaine HCl, Lidocaine HCl, or Ropivacaine HCl), flow rate and time of therapy, selecting between 100ml or 200ml pumps; .
OTCBB:BGMR) announced today that it has received licenses from The IKS (the Swiss FDA) to market two dosage strengths of Bupivacaine HCL Infusion solution in Switzerland.
Nasdaq:BGMR) today announced that it has received licenses from the UK Medicines Control Agency granting authorization to market two dosage strengths of Bupivacaine HCL Infusion Solution in the United Kingdom.
By infusing Bupivacaine HCl, a non-narcotic drug, directly into the site of the surgery, I-Flow's disposable PainBuster pain management kit can avoid the many undesirable side effects of systemic narcotic pain relievers such as morphine.